cholestyramine - Generic mfg.
vancomycin - Generic mfg.
Dificid (fidaxomicin) - Merck (MSD), Astellas
The Colitis Conundrum: Triple Pattern Severe Pancolitis With Discordant Infectious and Eosinophilic Features (ACG 2026) - Aug 29, 2026 - Abstract #P4920; Pres time: Oct 13, 2026; 10:30 AM - 04:00 PM; Location: Exhibit Halls A - D (Level 3); "He was treated with fidaxomicin and high-dose oral vancomycin, along with octreotide, cholestyramine, dietary modification, and supportive care. Finally, this case underscores a practical treatment gap: lack of FMT availability necessitated prolonged high-dose antimicrobial therapy, with potential impact on recovery and resource use. Figure: Colonoscopy findings" 
Discordant • Cardiovascular • Chronic Kidney Disease • Diabetes • Dyslipidemia • Gastroenterology • Gastrointestinal Disorder • Hematological Disorders • Hypertension • Hypotension • Immunology • Infectious Disease • Metabolic Disorders • Nephrology • Renal Disease • Septic Shock • Type 2 Diabetes Mellitus
https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=829300&rnd=0.2794697
 
Bahar Rehan MD 1; Mohammad Umar Memon MD 2; Yeshika Thapa MD 1; Murad Haddad MD 1; Yaseen Perbtani MD 2
 
Aug 29, 2026
 
Prev Next